Martindale Pharma listed among fastest-growing private equity-backed firms

Martindale Pharma has been ranked as one of the top 100 fastest-growing companies backed by private equity in 2012.

The specialty healthcare company has been listed in the Sunday Times Deloitte Buyout Track 100, which compiles the top performing mid-market private equity-backed companies with the fastest-growing profits in Britain.

Profit levels at Martindale Pharma have risen by 18 percent annually since AAC Capital Partners backed a 100 million-pound buyout of the firm from its original US owners in 2010.

Its customers include the NHS, Alliance Boots, Lloyds Pharmacy and the Co-operative Pharmacy, while its portfolio encompasses 30,000 formulations of unlicensed medicines.

Richard de Souza, chief executive officer of Martindale Pharma, said: "The success of Martindale Pharma is testament to the hard work and dedication of our employees over the last two years."

Last month, the company launched a generic version of latanoprost, a therapy for glaucoma based on Pfizer's branded drug Xalatan.